Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000664479 | SCV000788442 | pathogenic | Junctional epidermolysis bullosa gravis of Herlitz | 2017-11-21 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003558481 | SCV004297811 | pathogenic | not provided | 2023-02-22 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 549906). This premature translational stop signal has been observed in individual(s) with autosomal recessive junctional epidermolysis bullosa (PMID: 27375110). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Gln405Argfs*15) in the LAMA3 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in LAMA3 are known to be pathogenic (PMID: 10366601, 11810295, 12915477, 16473856, 17362460, 22434185, 23869449, 27827380, 28087116). |